Induced smoothing method | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Follow-up time (month) | Total cholesterol | HDL | Family history of dyslipidemia | |||||||
PE | SE | 95% CI | PE | SE | 95% CI | PE | SE | 95% CI | ||
\(\tau\)=0.05 | ||||||||||
6 | -2.50 | 0.79 | (-4.052, -0.943) | 2.21 | 0.66 | (0.908, 3.510) | 0.28 | 0.73 | (-1.139, 1.708) | |
12 | 0.83 | 1.00 | (-1.132, 2.791) | 0.21 | 0.75 | (-1.247, 1.675) | 1.47 | 0.76 | (-0.008, 2.952) | |
18 | -2.46 | 0.91 | (-4.251, -0.668) | 1.20 | 1.04 | (-0.832, 3.240) | -0.52 | 1.01 | (-2.504, 1.454) | |
24 | -2.27 | 0.92 | (-4.079, -0.466) | 1.62 | 1.11 | (-0.548, 3.794) | -1.14 | 0.94 | (-2.979, 0.694) | |
\(\tau\)=0.1 | ||||||||||
6 | -2.31 | 0.86 | (-4.005, -0.624) | 2.57 | 0.79 | (1.016, 4.128) | -0.33 | 0.76 | (-1.808, 1.157) | |
12 | -1.35 | 1.00 | (-3.312, 0.605) | 0.92 | 0.95 | (-0.947, 2.792) | -0.39 | 1.05 | (-2.451, 1.665) | |
18 | -1.93 | 0.90 | (-3.691, -0.161) | 1.22 | 1.08 | (-0.896, 3.344) | -0.80 | 1.18 | (-3.107, 1.509) | |
24 | -3.49 | 1.07 | (-5.591, -1.387) | 2.58 | 1.13 | (0.372, 4.784) | -2.06 | 1.31 | (-4.633, 0.516) | |
\(\tau\)=0.15 | ||||||||||
6 | -1.20 | 0.61 | (-2.389, -0.004) | 2.57 | 1.02 | (0.574, 4.572) | -0.80 | 0.88 | (-2.535, 0.927) | |
12 | -2.77 | 1.65 | (-6.007, 0.475) | 2.39 | 1.84 | (-1.217, 5.996) | -1.61 | 1.61 | (-4.764, 1.547) | |
18 | -3.03 | 1.51 | (-5.997, -0.063) | 2.55 | 1.65 | (-0.688, 5.784) | -2.03 | 1.65 | (-5.264, 1.202) | |
24 | -3.58 | 1.71 | (-6.925, -0.236) | 3.88 | 1.86 | (0.228, 7.528) | -2.92 | 1.84 | (-6.520, 0.682) | |
\(\tau\)=0.2 | ||||||||||
6 | -2.22 | 1.38 | (-4.928, 0.497) | 2.40 | 1.51 | (-0.559, 5.368) | -1.43 | 1.33 | (-4.031, 1.175) | |
12 | -4.84 | 3.09 | (-10.891, 1.211) | 4.72 | 3.21 | (-1.576, 11.013) | -3.46 | 2.76 | (-8.869, 1.954) | |
18 | -4.82 | 3.37 | (-11.419, 1.782) | 5.54 | 4.11 | (-2.503, 13.589) | -4.21 | 3.23 | (-10.543, 2.119) | |
24 | -4.64 | 2.74 | (-10.013, 0.735) | 4.55 | 2.69 | (-0.718, 9.827) | -3.78 | 2.47 | (-8.616, 1.060) |